IT

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

Some of NIH's and NHGRI's challenge grants will give priorities to ethical issues that confront genomics, pharmacogenomics, and biomedicine.

Paired Ends

Premium

Helaman Escobar, John Keilty, Lutz Kirchrath

The Northwest Association for Biomedical Research has received a three year, $1.3 million grant from the National Science Foundation to support its education outreach programs.

Looking to support local industry and nurture Ireland's economic recovery, University College Dublin and Trinity College Dublin will combine their existing programs in tech transfer, enterprise development, industry relations, and post-graduate entrepreneurial education, largely in the area of life sciences.

The company will use the Expressionist and Phylosopher software in its search for transplantation and autoimmune biomarkers.

Pfizer La Jolla Incubator, Chromocell, NJEDA Biotechnology Development Center, Wockhardt USA LLC, Acorda Therapeutics, Eastman Business Park, Qatar Science & Technology Park, and more…

People in the News

Kevin Conroy has been named the new president and CEO of Exact Sciences, while Don St. Pierre is serving as the acting director of FDA's Office of In Vitro Diagnostics, plus more.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.